The Worst Phony Cancer Cures

Stephen Barrett, MD, Retired Psychiatrist; Medical Editor for and 24 other consumer-protection Web sites; Publisher for Consumer Health Digest; Chapel Hill, NC; Email: Q: Who tops your list as the most brazen promoters of phony cancer cures in the past 25 years? A: Three people come to mind: Gregory Caplinger, Hulda Clark, and […]

Nordic Country Tobacco Control

Astrid Nylenna, MD, Acting Head of Department, Department of Global Health, Norwegian Directorate of Health, Oslo, Norway; Email: Follow Astrid Q: Norway has been very active in tobacco control and prevention with some success. To what do you attribute the success Norway has had and are there any lessons from other Scandinavian countries that […]

Surprise: Vitamin K2 and Cancer

Micki Jacobs, Independent Researcher, Dayton, OH; Email: Q: You know a great deal about Vitamin K2 and its precursors in human health and disease. What is the best evidence of any value of Vitamin K2, Menadione, Menaquinone-4, and Menaquinone-7 in the prevention or treatment of any forms of cancer? A: Evidence and interest for […]

Precision Medicine in the Universal Healthcare System in the Netherlands

Jack A. Schalken, PhD, Professor of Experimental Urology, Radboud University Medical Center, Nijmegen, NL Email: Q: Science is universal but the practice of medicine varies widely by geography, economics, and culture. The Netherlands is an advanced developed country with universal healthcare. How does your country approach the issue of precision or molecular oncology? A: […]

The Role of “Rapid Science” in Facilitating and Rewarding Collaboration in Biomedical Research

Sarah Greene, MS, Chief Executive Officer, Rapid Science, Brooklyn, NY; Email Follow SarahFollow Rapid Science Q: You are the leader of Rapid Science, an innovative initiative intended to speed up the process of research and validation of new information, and its use in practice, especially in Cancer. Can you explain this effort briefly for […]

Q&A: Air Traffic Control for Cancer

David K. Cundiff, MD, Retired internist and palliative care physician from LA County + USC Medical Center; Email: Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, Stanford University; Email: Q: After May 17, 2017, you and Jeff Shrager engaged in a robust discussion about the place, if any, […]

Options to Treat a Glioblastoma

Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY; Email: Phone: 888-295-4740 Follow Al Q: You direct an established foundation that supports research and information about brain tumors. What would you do if you yourself were diagnosed with a glioblastoma multiforme (GBM)? A: Now that GBMs are in […]

Lung Cancer Screening…The Clock is Ticking

Paul R Billings MD, PhD, CEO and Chairman of Synergenz LTD Q: Lung cancer screening of smokers (spiral CT over 3 years) is paid for by CMS (reimbursement), has a B endorsement from USPTF (method endorsement), and lots of NEJM papers (academic evidence). As many as 8M eligibles noted since 2012. No more than 400K […]

The Value of Molecular Disease Models for Cancer Treatment Planning

Smruti Vidwans, PhD, Chief Science Officer at CollabRx Q: You have been notified that your article entitled “A Melanoma Molecular Disease Model” is among the top 10% of most cited articles in 10 years at PLOS ONE. Congratulations. What is the essence of that paper, why it is important, and what has changed in the […]

How to Initiate Treatment for Chronic Myelogenous Leukemia March 2016 vs July 2017

Jerald P. Radich, MD, Director of the Molecular Oncology Lab at the Fred Hutchinson Cancer Research Center, and Professor of Medicine at the University of Washington School of Medicine Q: In March 2016, we published your blog about how to initiate therapy for an adult patient newly diagnosed with chronic myeloid leukemia (CML). As of […]